Cassava Sciences, Inc. (SAVA)
| Previous Close | 84.86 |
| Open | 81.63 |
| Bid | 86.81 x 1100 |
| Ask | 87.20 x 1300 |
| Day's Range | 80.68 - 88.63 |
| 52 Week Range | 2.78 - 146.16 |
| Volume | 1,773,610 |
| Avg. Volume | 3,634,540 |
| Market Cap | 3.519B |
| Beta (5Y Monthly) | 1.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.30 |
| Earnings Date | Aug. 03, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec. 13, 2012 |
| 1y Target Est | 116.20 |
- GlobeNewswire
Cassava Sciences Reports Second Quarter 2021 Financial Results
- Conference Call Today at 9 a.m. ET -AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the second quarter ended June 30, 2021. Net loss for the second quarter ended June 30, 2021, was $5.1 million, or $0.13 per share, compared to a net loss of $1.1 million, or $0.05 per share, for the same period in 2020. Net cash used in operations was $7.4 million
- Motley Fool
5 Ultra-Popular Stocks to Avoid Like the Plague in August
Movie theater chain and chief meme stock AMC Entertainment (NYSE: AMC) is a liable to be a fixture on this monthly list until it either resolves its operating inefficiencies or retraces another 85% -- whichever comes first. The premise for avoiding AMC is simple: The math doesn't make sense. Although AMC was able to raise in the neighborhood of $2.2 billion in capital, it's still contending with over $5.4 billion in debt, as of the end of March, has $473 million in deferred rental obligations, and is dealing with multiple billions of dollars in remaining lease obligations.
- GlobeNewswire
Cassava Sciences Announces Conference Call for Second Quarter Financial Results
- Call-in on Tuesday, August 3rd at 9 a.m. ET -AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, will release financial results for the period ending June 30, 2021 on Tuesday, August 3, 2021 before the market opens, followed by a conference call. Remi Barbier, President & CEO, and Eric Schoen, Chief Financial Officer, will host a conference call to review financial results and to preview the Company’s g
